Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review)

A severe immune response in patients with coronavirus disease 2019 (COVID-19) can cause a potentially lethal unconstrained inflammatory cytokine storm, known as cytokine release syndrome (CRS). The present study provides an overview of the biology underlying CRS and how targeted inhibition of interl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jia-Jie, Zhang, Li-Na, Hou, Hu, Xu, Lingqing, Ji, Kunmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690237/
https://www.ncbi.nlm.nih.gov/pubmed/33262810
http://dx.doi.org/10.3892/etm.2020.9456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690237/
https://www.ncbi.nlm.nih.gov/pubmed/33262810
http://dx.doi.org/10.3892/etm.2020.9456

Ejemplares similares